Fig. 4.

Effects of prolonged intake of desloratadine on blood lipids (fasted), glucose (fasted), and insulin (fasted and nonfasted). group C, control group; group D, desloratadine-treated group; HDL/LDL, high/low-density lipoprotein. A–D and I–J: measurements in systemic blood. panels F–H: measurements in portal blood normalized to corresponding levels in systemic blood under the same conditions (nonfasted). *Significant differences (P < 0.05) between the control group and group D; #significant differences (P < 0.05) between nonfasted and fasted insulin within each experimental group; n = 6 for each group.